Estimate Recalculated Apr 10, 2025 08:46PM EST
Eric J Ende has an estimated net worth of $4.9 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Matinas BioPharma Holdings, Inc., AVADEL PHARMACEUTICALS PLC, NeuBase Therapeutics, Inc., and PROGENICS PHARMACEUTICALS INC.
Eric J Ende's CIK is 0001494386
2019 was Eric J Ende's most active year for acquiring shares with 12 total transactions. Eric J Ende's most active month to acquire stocks was the month of July. 2011 was Eric J Ende's most active year for disposing of shares, totalling 3 transactions. Eric J Ende's most active month to dispose stocks was the month of March. 2017 saw Eric J Ende paying a total of $876,000.00 for 562,201 shares, this is the most they've acquired in one year. In 2011 Eric J Ende cashed out on 11,875 shares for a total of $542,830.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!